Tuesday , October 24 2017
Home / Evan D. Rosen, M.D., Ph.D

Evan D. Rosen, M.D., Ph.D

Evan D. Rosen, M.D., Ph.D
Assistant Professor of Medicine, Harvard Medical School; Medical Director, Diabetes, Veritas Medicine.

Type 1 Diabetes: Nipping Things in the Bud

www.diabetesincontrol.com_rosen_resist4

Evan David Rosen, M.D., Ph.D. Assistant Professor of Medicine, Harvard Medical School has taken a thorough look at the newest immunosuppressives and how they work for diabetes patients. His article Nipping Things in the Bud brings to light some of the uses for these medications and why research is ongoing. ...

Read More »

Obesity: How big a problem is it?

www.diabetesincontrol.com_rosen_resist4

Evan David Rosen, M.D., Ph.D. weighs in with his opinion as to how the obestiy numbers got to where they are in his new article Obesity: How big a problem is it? Evan David Rosen, M.D., Ph.D. Assistant Professor of Medicine, Harvard Medical School As any casual reader of the ...

Read More »

A New Face in The Crowd: FGF-21

www.diabetesincontrol.com_rosen_resist4

Although we have a lot of information from ADA Evan David Rosen, M.D., Ph.D. Assistant Professor of Medicine, Harvard Medical School, brings us more research he uncovered about a new protein like drug from Lilly. FGF-21 is unique because as an anti-diabetic drug it appears to increase glucose uptake in ...

Read More »

Some Further Inflammatory Remarks

www.diabetesincontrol.com_rosen_resist4

NF-kB is an inflammation activation protein that seems to work in the liver. What does this have to with diabetes? Everything according to Evan David Rosen, M.D., Ph.D. Assistant Professor of Medicine, Harvard Medical School. You can find out why, by reading Some Further Inflammatory Remarks. To an endocrinologist, there ...

Read More »

Low Testosterone in Type 2 Diabetes; A Hidden Epidemic?

Evan D. Rosen, M.D., Ph.D.

Evan David Rosen, M.D., Ph.D. Assistant Professor of Medicine, Harvard Medical School addresses another hidden factor in type 2 diabetes. Low Testosterone; A Hidden Epidemic? Among endocrinologists, it’s well-known that patients with type 1 diabetes are at risk for other hormonal disorders, including hypothyroidism, premature ovarian failure, and Addison’s disease ...

Read More »

Update on Resistin

www.diabetesincontrol.com_rosen_VM_diabetes_460x68

Evan David Rosen, M.D., Ph.D. Assistant Professor of Medicine, Harvard Medical School A few years ago I wrote about an interesting new molecule called resistin. Resistin was isolated independently by three different groups looking for proteins involved in inflammation, fat cell formation, and insulin resistance in mice. For those interested ...

Read More »